共 18 条
[1]
McDougal E.G., Burnham S.J., Johnson G., Rifampicin protection against experimental graft sepsis, J. Vasc. Surg., 4, pp. 5-7, (1986)
[2]
Moore W.S., Chvapil M., Seiffert G., Keown K., Development of an infection‐resistant vascular prosthesis, Arch. Surg., 116, pp. 1403-1407, (1981)
[3]
Shue W.B., Worosilo S.C., Donetz A.P., Trooskin S.Z., Harvey R.A., Creco R.S., Prevention of vascular prosthetic infection with an antibiotic‐bonded Dacron graft, J. Vusc. Surg., 8, pp. 600-605, (1988)
[4]
Clark R.E., Magraf H.W., Antibacterial vascular grafts with improved thrombo resistance, Arch. Surg., 109, pp. 150-162, (1974)
[5]
Krag L.E., Solheim K., Antibiotic binding polytevafluoroethylene via glucosaminoglycan‐keratin luminal coating, Surgery, 100, pp. 629-634, (1986)
[6]
Kempczinski R.F., Discussion following Moore et al. Development of an infection‐resistant vascular prosthesis. Discussion at the 29th Scientific Meeting of the International Cardiovascular Society, North Amer. Chapter, Dallas, Arch. Surg., 116, (1981)
[7]
Powell T.W., Burnham S.J., Johnson G., A passive system using Rifampicin to create an infection‐resistant vascular prosthesis, Surgery, 94, pp. 765-769, (1983)
[8]
Ashton T.R., Cummingham J.D., Paton D., Maini R., (1990)
[9]
Cruickshank R., Duguid J.P., Marmion B.P., Swain R.H.A., Medical Microbiology, (1975)
[10]
Bunt T.J., Synthetic vascular graft infections. I. Graft Infections, Surgery, 93, pp. 733-746, (1983)